Patents by Inventor Alvin C. Bach, II

Alvin C. Bach, II has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
    Publication number: 20140296164
    Abstract: The present invention describes peptide drugs that inhibit the interaction between CAL and CFTR, and other proteins in cystic fibrosis and other diseases. These invented drugs have been chemically optimized to impart solubility, stability, cell permeability, mucus penetration, intracellular targeting and sequestration, increased potency and non-immunogenicity, while conserving and imparting efficacy. This renders these compositions suitable for human use, which is exemplified by use in the treatment of cystic fibrosis.
    Type: Application
    Filed: March 29, 2014
    Publication date: October 2, 2014
    Applicant: CALISTA THERAPEUTICS, INC.
    Inventors: Andrew Peter Mallon, Alvin C. Bach, II